R
rabbitlily2
@rabbitlily2
https://acadiacs.org/rc/buy-methylone-crystal/
https://acadiacs.org/rc/buy-methylone-crystal/
A Phase 3 clinical trial of LMTM (TauRx0237 or LMT-X), a by-product of methylene blue, failed to indicate any profit against cognitive or functional decline in individuals with delicate to moderate Alzheimer's illness. Disease progression for each the drug and the placebo had been virtually equivalent. The addition of a powerful decreasing agent, similar to ascorbic acid, to a sulfide-containing answe